| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $585.9M | +51.1% |
| Cost of Revenue | $202.4M | +47.4% |
| Gross Profit | $383.5M | +53.1% |
| R&D Expense | $264.0M | +63.1% |
| SG&A Expense | $125.7M | +15.4% |
| Operating Income | -$462.7M | -36.2% |
| Pre-tax Income | -$446.3M | -31.4% |
| Income Tax | $6.3M | +98.3% |
| Net Income | -$452.6M | -32.0% |
| EPS (Basic) | -$1.62 | +11.0% |
| EPS (Diluted) | -$1.62 | +11.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $435.8M | -68.3% |
| Accounts Receivable | $178.2M | +29.6% |
| Current Assets | $2.20B | -1.3% |
| Total Assets | $2.34B | +0.1% |
| Current Liabilities | $424.3M | +21.9% |
| Long-term Debt | $1.08B | +0.4% |
| Total Liabilities | $1.58B | +5.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$157.3M | -49.8% |
| Capital Expenditures | $4.1M | +14.5% |
| Investing Cash Flow | -$865.8M | -116.1% |
| Financing Cash Flow | $82.2M | -95.5% |
| Free Cash Flow | -$161.5M | -48.6% |
| Stockholders' Equity |
| $769.5M |
| -9.5% |